Accurate and timely detection of viral infections is essential for clinical management, epidemiological surveillance, infection control, and public health response. Viral diagnostics has evolved from traditional virus isolation to highly sensitive molecular techniques that can identify pathogens within hours.
Nucleic Acid Amplification Tests
Polymerase chain reaction (PCR) is the cornerstone of molecular viral diagnostics. Reverse transcription PCR (RT-PCR) converts viral RNA to complementary DNA (cDNA) using reverse transcriptase, followed by PCR amplification, making it the gold standard for RNA virus detection including SARS-CoV-2, influenza, HIV, and hepatitis C virus. Real-time quantitative PCR (qPCR) uses fluorescent probes to monitor amplification in real time, providing both detection and quantification of viral load. Digital PCR partitions the sample into thousands of individual reactions, enabling absolute quantification without standard curves and improved detection of low-abundance targets. Multiplex PCR assays simultaneously detect multiple viruses in a single reaction, such as respiratory virus panels that test for influenza A and B, respiratory syncytial virus, adenovirus, and human metapneumovirus. Isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) amplify nucleic acids at constant temperature, enabling point-of-care testing without thermal cyclers.
Serological Detection Methods
Serological tests detect antibodies produced by the host immune response against viral antigens, indicating current or past infection. Enzyme-linked immunosorbent assay (ELISA) is the most widely used format, with indirect ELISA detecting antiviral antibodies in patient serum and sandwich ELISA detecting viral antigens directly. Rapid diagnostic tests (RDTs), typically based on lateral flow immunochromatography, provide results in 15–30 minutes and are widely used for HIV, dengue, and SARS-CoV-2 testing at the point of care. Neutralization assays measure the ability of patient antibodies to block viral infection in cell culture, providing functional information about protective immunity that is particularly important for vaccine evaluation. Western blotting is used as a confirmatory test for HIV, detecting antibodies against specific viral proteins such as gp120, gp41, and p24.
Antigen Detection Methods
Direct antigen tests detect viral proteins in clinical samples, providing rapid results at lower cost than molecular methods. Immunofluorescence assays (IFAs) use fluorescently labeled antibodies to detect viral antigens directly in patient cells or tissue sections, commonly used for respiratory viruses (influenza, RSV) and herpesviruses. Lateral flow immunochromatographic assays, such as rapid antigen tests for SARS-CoV-2, use antibodies conjugated to colored nanoparticles that bind viral antigens and produce a visible line on a test strip. While antigen tests are generally less sensitive than molecular methods, they are faster, cheaper, and more suitable for widespread screening.
Virus Isolation in Cell Culture
Viral culture involves inoculating clinical samples onto susceptible cell lines and observing cytopathic effects (CPE), such as syncytia formation (respiratory syncytial virus), cell rounding (enteroviruses), and plaque formation (influenza virus). Shell vial culture enhances detection by centrifugation of the inoculum onto the cell monolayer followed by immunostaining for viral antigens after 24–48 hours, compared to the 3–14 days required for traditional culture. While culture is slow and requires specialized facilities, it remains important for virus discovery, antiviral susceptibility testing, and the production of viral stocks for research and vaccine development.
Microscopy-Based Detection
Electron microscopy can visualize virus particles directly in clinical samples, identifying viruses by their characteristic morphology — icosahedral (adenovirus, herpesvirus), helical (influenza, Ebola), or complex (poxvirus) — and is particularly useful for detecting unknown or unexpected viruses. Immunoelectron microscopy uses antibody labeling to specifically identify virus particles. While not suitable for routine diagnostics due to cost and expertise requirements, electron microscopy played a critical role in discovering many viruses, including SARS-CoV-1 and norovirus.
Sequencing-Based Diagnostics
Next-generation sequencing (NGS) enables unbiased detection of known and novel viruses in clinical samples without requiring prior knowledge of the pathogen sequence. Metagenomic NGS sequences all nucleic acid in a sample, allowing identification of viruses, bacteria, fungi, and parasites simultaneously. Targeted NGS panels enrich for viral sequences using probe capture or multiplex PCR before sequencing, increasing sensitivity for known pathogens. Sequencing also provides information about viral genotype, drug resistance mutations, and phylogenetic relationships for outbreak investigation. While still expensive and computationally intensive, sequencing is increasingly used in clinical diagnostics, particularly for complex cases where conventional testing is negative.
Point-of-Care and Emerging Technologies
Point-of-care testing brings viral diagnostics closer to the patient, reducing turnaround time from days to minutes. Microfluidic lab-on-a-chip devices integrate sample preparation, amplification, and detection on a single cartridge, with examples including the GeneXpert system for HIV, tuberculosis, and SARS-CoV-2. CRISPR-based diagnostics (SHERLOCK, DETECTR) use Cas enzymes programmed to recognize specific viral nucleic acid sequences, coupled with reporter molecules that generate a fluorescent or colorimetric signal, achieving attomolar sensitivity without complex instrumentation. Biosensors using nanomaterials, aptamers, and electrochemical detection are under development for rapid, portable viral detection.
